Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services

British Journal of Clinical Pharmacology

Volumn 84, Issue 3, 2018, Pages 568-578

  Panchaud, Alice ^a,b,c   Rousson, Valentin ^d   Vial, Thierry ^e   Bernard, Nathalie ^e   Baud, David ^b   Amar, Emmanuelle ^f   De Santis, Marco ^g   Pistelli, Alessandra ^h   Dautriche, Anne ⁱ   Beau Salinas, Frederique ^j   Cassina, Matteo ^k   Dunstan, Hannah ^l   Passier, Anneke ^m   Kaplan, Yusuf Cem ⁿ   Duman, Mine Kadioglu ^o   Maňáková, Eva ^p   Eleftheriou, Georgios ^q   Klinger, Gil ^r,s   Winterfeld, Ursula ^b   Rothuizen, Laura E ^b   Buclin, Thierry ^b   Csajka, Chantal ^a   Hernandez Diaz, Sonia ^c   more..

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ LYON 1   (France)

^g CATHOLIC UNIVERSITY   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

ⁱ DIJON UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF TOURS   (France)

^k UNIVERSITY OF PADOVA   (Italy)

^l UKTIS   (United Kingdom)

^m NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

ⁿ IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^o KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^p CHARLES UNIVERSITY   (Czech Republic)

^q Poison Control Center   (Italy)

^r RABIN MEDICAL CENTER   (Israel)

^s TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

diabetes; metformin; observational study; pregnancy; spontaneous abortion; teratogen

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; DIABETES MELLITUS; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INFORMATION SERVICE; INSULIN RESISTANCE; MACROSOMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; OBSERVATIONAL STUDY; PREGESTATIONAL DIABETES; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SPONTANEOUS ABORTION; STILLBIRTH; TERATOLOGY; CLINICAL TRIAL; PREGNANCY; PREGNANCY COMPLICATION;

ABORTION, SPONTANEOUS; ADULT; COHORT STUDIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; STILLBIRTH;

EID: 85041952645     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.13481     Document Type: Article

References (39)

1. Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab 2014; 20: 953–966.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364–1379.
3. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009; 113: 193–205.
4. Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol 2015; 80: 1224–1234.
5. National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. London: NICE, 2015.
6. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358: 2003–2015.
7. Li G, Zhao S, Cui S, Li L, Xu Y, Li Y. Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet 2015; 292: 111–120.
8. Beyuo T, Obed SA, Adjepong-Yamoah KK, Bugyei KA, Oppong SA, Marfoh K. Metformin versus insulin in the management of pre-gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PloS One 2015; 10: e0125712.
9. Ainuddin JA, Karim N, Zaheer S, Ali SS, Hasan AA. Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J Diabetes Res 2015; 2015: 325851.
10. Tertti K, Laine K, Ekblad U, Rinne V, Ronnemaa T. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus. Acta Diabetol 2014; 51: 731–738.
11. Tuchmann-Duplessis H, Mercier-Parot L. Repercussions of a hypoglycemic drug, N-N-dimethylbiguanide HCl, on gestation and fetal development in rats. C R Hebd Seances Acad Sci 1961; 253: 321–323.
12. Denno KM, Sadler TW. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis. Teratology 1994; 49: 260–266.
13. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86: 658–663.
14. Cassina M, Dona M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update 2014; 20: 656–669.
15. Schaefer C, Hannemann D, Meister R. Post-marketing surveillance system for drugs in pregnancy – 15 years experience of ENTIS. Reprod Toxicol 2005; 20: 331–343.
16. Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome – methodological considerations. Reprod Toxicol 2008; 26: 36–41.
17. Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, De Santis M, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol 2012; 52: 1844–1851.
18. Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, et al. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015; 35: 250–259.
19. Klieger-Grossmann C, Weitzner B, Panchaud A, Pistelli A, Einarson T, Koren G, et al. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J Clin Pharmacol 2012; 52: 766–770.
20. Merks JH, van Karnebeek CD, Caron HN, Hennekam RC. Phenotypic abnormalities: terminology and classification. Am J Med Genet A 2003; 123A: 211–230.
21. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003; 67: 193–201.
22. Meister R, Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies – analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 2008; 26: 31–35.
23. Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 2013; 66: 648–653.
24. Scheen AJ, Van Gaal LF. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes. Lancet Diabetes Endocrinol 2014; 2: 911–922.
25. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990–2002. Diabet Med 2003; 20: 734–738.
26. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997; 315: 275–278.
27. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995; 18: 1446–1451.
28. Reece EA. Diabetes-induced birth defects: What do we know? What can we do? Curr Diab Rep 2012; 12: 24–32.
29. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617–1623.
30. Miodovnik M, Lavin JP, Knowles HC, Holroyde J, Stys SJ. Spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 1984; 150: 372–376.
31. Miodovnik M, Skillman C, Holroyde JC, Butler JB, Wendel JS, Siddiqi TA. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 1985; 153: 439–442.
32. Miodovnik M, Mimouni F, Tsang RC, Ammar E, Kaplan L, Siddiqi TA. Glycemic control and spontaneous abortion in insulin-dependent diabetic women. Obstet Gynecol 1986; 68: 366–369.
33. Sutherland HW, Pritchard CW. Increased incidence of spontaneous abortion in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1987; 156: 135–138.
34. Wright AD, Nicholson HO, Pollock A, Taylor KG, Betts S. Spontaneous abortion and diabetes mellitus. Postgrad Med J 1983; 59: 295–298.
35. Palomba S, Falbo A, Orio F Jr, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2009; 92: 1646–1658.
36. van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG 2015; 122: 1002–1009.
37. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009; 301: 636–650.
38. Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol 2004; 191: 969–974.
39. Beck E, Lechner A, Schaefer C. Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod Toxicol 2017; 67: 79–84.